TrialActa pharmacologica Sinica2015

The efficacy and safety of weekly 35-mg risedronate dosing regimen for Chinese postmenopausal women with osteoporosis or osteopenia: 1-year data.

Jie-mei Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.